<TEXT>&#2;<DATELINE>2020-04-06</DATELINE><TITLE>Is Global BCG Vaccination Coverage Relevant To The Progression Of SARS-CoV-2 Pandemic?</TITLE><BODY>Abstract The lower than expected number of SARS-CoV-2 cases in countries with fragile health systems is puzzling. Herein, we hypothesize that BCG vaccination policies adopted by different countries might influence the SARS-CoV-2 transmission patterns and/or COVID-19 associated morbidity and mortality through the vaccineâ€™s capacity to confer heterologous protection. We also postulate that until a specific vaccine is developed, SARS-CoV-2 vulnerable populations could be immunized with BCG vaccines to attain heterologous nonspecific protection from the new coronavirus.&#3;</BODY></TEXT>